Rock Springs Capital Management LP Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$1.6T
Holdings
137
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (137 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | OTICEUROTONOMY INC | 210,000 | $3.8B | 0.24% | |
| 102 | —CARDIOME PHARMA CORP | 1,200,000 | $3.8B | 0.24% | |
| 103 | INVAINNOVIVA INC | 336,900 | $3.7B | 0.23% | |
| 104 | PRGOPERRIGO CO PLC | 37,900 | $3.5B | 0.22% | |
| 105 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 524,089 | $3.4B | 0.21% | |
| 106 | MDMEDNAX INC | 50,000 | $3.3B | 0.21% | |
| 107 | —NABRIVA THERAPEUTICS AG | 426,000 | $3.0B | 0.19% | |
| 108 | —STERIS PLC | 40,000 | $2.9B | 0.18% | |
| 109 | ITCIEURINTRA CELLULAR THERAPIES INC | 190,000 | $2.9B | 0.18% | |
| 110 | —CIDARA THERAPEUTICS INC | 250,000 | $2.9B | 0.18% | |
| 111 | ASMBASSEMBLY BIOSCIENCES INC | 390,000 | $2.8B | 0.18% | |
| 112 | MCRB1EURSERES THERAPEUTICS INC | 220,000 | $2.7B | 0.17% | |
| 113 | —DBV TECHNOLOGIES S A | 73,000 | $2.7B | 0.17% | |
| 114 | TTPHEURTETRAPHASE PHARMACEUTICALS I | 662,500 | $2.5B | 0.16% | |
| 115 | —GENOCEA BIOSCIENCES INC | 480,000 | $2.5B | 0.15% | |
| 116 | SCYXEURSCYNEXIS INC | 635,000 | $2.5B | 0.15% | |
| 117 | —EGALET CORP | 300,000 | $2.3B | 0.14% | |
| 118 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 98,000 | $2.3B | 0.14% | |
| 119 | —AMSURG CORP | 32,500 | $2.2B | 0.14% | |
| 120 | —DIMENSION THERAPEUTICS INC | 271,370 | $2.2B | 0.14% | |
| 121 | NVCRNOVOCURE LTD | 214,316 | $1.8B | 0.11% | |
| 122 | NVAXNOVAVAX INC | 852,500 | $1.8B | 0.11% | |
| 123 | DVAXDYNAVAX TECHNOLOGIES CORP | 165,000 | $1.7B | 0.11% | |
| 124 | BHCVALEANT PHARMACEUTICALS INTL | 68,600 | $1.7B | 0.11% | |
| 125 | EX9EXELIXIS INC | 125,000 | $1.6B | 0.10% | |
| 126 | —CHIASMA INC | 492,500 | $1.4B | 0.09% | |
| 127 | —ANTHERA PHARMACEUTICALS INC | 450,000 | $1.4B | 0.09% | |
| 128 | —ATYR PHARMA INC | 433,500 | $1.4B | 0.09% | |
| 129 | —BLUEBIRD BIO INC | 20,000 | $1.4B | 0.09% | |
| 130 | CERNCHFCERNER CORP | 20,000 | $1.2B | 0.08% | |
| 131 | INSYEURINSYS THERAPEUTICS INC NEW | 100,000 | $1.2B | 0.07% | |
| 132 | —WRIGHT MED GROUP INC | 1,000,000 | $1.1B | 0.07% | |
| 133 | MDGLMADRIGAL PHARMACEUTICALS INC | 63,000 | $799.0M | 0.05% | |
| 134 | —CERULEAN PHARMA INC | 625,000 | $654.0M | 0.04% | |
| 135 | —OREXIGEN THERAPEUTICS INC | 165,300 | $549.0M | 0.03% | |
| 136 | INFIQINFINITY PHARMACEUTICALS INC | 270,000 | $421.0M | 0.03% | |
| 137 | —ARIAD PHARMACEUTICALS INC | 25,000 | $342.0M | 0.02% |
PreviousPage 2 of 2